SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 139 filers reported holding SERES THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,542,858 | +33.9% | 2,749,100 | +169.4% | 0.02% | +26.7% |
| Q2 2023 | $4,887,716 | +194.4% | 1,020,400 | +248.5% | 0.02% | +200.0% |
| Q1 2023 | $1,660,176 | -57.6% | 292,800 | -58.1% | 0.01% | -61.5% |
| Q4 2022 | $3,917,760 | -35.0% | 699,600 | -25.5% | 0.01% | -45.8% |
| Q3 2022 | $6,031,000 | +424.9% | 939,429 | +180.4% | 0.02% | +380.0% |
| Q2 2022 | $1,149,000 | -94.3% | 335,000 | -65.6% | 0.01% | -94.7% |
| Q1 2021 | $20,068,000 | +676.9% | 974,671 | +824.3% | 0.09% | +623.1% |
| Q4 2020 | $2,583,000 | -45.2% | 105,446 | -36.6% | 0.01% | -45.8% |
| Q3 2020 | $4,710,000 | – | 166,388 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |